The most interesting part of this presentation was the FDA giving guidance "including feedback on part 2 of the study." Remember, that's after they have data on the maximum feasible dose, toxicity and tumor response for the first 40 odd patients in phase 1 of the study. They wouldn't be doing that if it wasn't already likely. IND clearance, found under the 'contingencies' section of the latest half yearly report, has been given a 90% probability by the board. I like those odds.
The most interesting part of this presentation was the FDA...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.004(6.67%) |
Mkt cap ! $415.2M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.5¢ | $755.1K | 13.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 375095 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 756028 | 16 |
View Market Depth
| Last trade - 10.53am 24/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |